Google DeepMind AlphaFold 3 Accelerates Drug Discovery with All-Molecule Predictions

Google DeepMind released AlphaFold 3, extending its revolutionary protein structure prediction to all biological molecules: DNA, RNA, small molecules (drugs), and their interactions. The model predicts how potential drug molecules bind to target proteins with unprecedented accuracy, potentially cutting years from early-stage drug discovery. Pharmaceutical companies AstraZeneca, Eli Lilly, and Recursion are already using AlphaFold 3 in their pipelines. The structure database is freely accessible for academic research, containing predictions for 200M+ molecules.